Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Syal

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 1, 2022
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort StudyNghia H Nguyen, Jiyu Luo, Paulina Paul, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisParakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
Journal of Crohn'S & Colitis|July 2, 2024
Ileal Paneth Cell Phenotype is a Cellular Biomarker for Pouch Complications in Ulcerative ColitisChangqing Ma, Talin Haritunians, Anas K Gremida, et al.
The American Journal of Gastroenterology|August 16, 2022
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort StudyPhillip Gu, Jiyu Luo, Jihoon Kim, et al.
Gastroenterology|March 15, 2024
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel DiseaseMichelle Khrom, Millie Long, Shishir Dube, et al.
Gastroenterology|August 15, 2021
Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel DiseaseValeriya Pozdnyakova, Gregory J Botwin, Kimia Sobhani, et al.
Gut|April 20, 2023
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosisMarzieh Akhlaghpour, Talin Haritunians, Shyam K More, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 1, 2022
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort StudyNghia H Nguyen, Jiyu Luo, Paulina Paul, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisParakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
Journal of Crohn'S & Colitis|July 2, 2024
Ileal Paneth Cell Phenotype is a Cellular Biomarker for Pouch Complications in Ulcerative ColitisChangqing Ma, Talin Haritunians, Anas K Gremida, et al.
The American Journal of Gastroenterology|August 16, 2022
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort StudyPhillip Gu, Jiyu Luo, Jihoon Kim, et al.
Gastroenterology|March 15, 2024
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel DiseaseMichelle Khrom, Millie Long, Shishir Dube, et al.
Gastroenterology|August 15, 2021
Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel DiseaseValeriya Pozdnyakova, Gregory J Botwin, Kimia Sobhani, et al.
Gut|April 20, 2023
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosisMarzieh Akhlaghpour, Talin Haritunians, Shyam K More, et al.
Pageof 6